loader2
Partner With Us NRI

Alpa Laboratories Ltd share Price Today

Company details

94.70
97.50
55.00
115.00
6M Return 32.92%
1Y Return 56.46%
Mkt Cap.(Cr) 202.62
Volume 34,902
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 34,902

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Alpa Laboratories Ltd shares SWOT Analysis

Strengths (5)

  • Rising Net Cash Flow and Cash from Operating activity
  • Company with Low Debt
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Weakness (2)

  • Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
  • Fall in Quarterly Revenue and Net Profit (YoY)

Opportunity (1)

  • RSI indicating price strength

Threats (1)

  • Increasing Trend in Non-Core Income

Resistance and support

R1 96.4
R2 97.9
R3 99.5
Pivot

94.80

S1 93.3
S2 91.7
S3 90.2
EMA SMA
92.0
94.0
93.8
88.3
90.9
95.2
99.1
87.7
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
CITADEL SECURITIES INDIA MARKETS PRIVATE LIMITED Bulk Purchase 2024-02-07 110.06 118734 NSE
CITADEL SECURITIES INDIA MARKETS PRIVATE LIMITED Bulk Sell 2024-02-07 112.05 36809 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2023-11-22 103.13 112936 NSE
Name Category Shares
PARESH CHAWLA PROMOTER 17.52%
MAHENDRA SINGH CHAWLA PROMOTER 13.82%
PRAVIN SHAH PROMOTER 5.75%
BAKULESH SHAH PROMOTER 4.88%
SHITUL SHAH PROMOTER 4.4%
RIMA SHAH PROMOTER 3.68%
ASHA CHAWLA PROMOTER 2.93%
RUPAL SHAH PROMOTER 2.66%
SONI CHAWLA PROMOTER 1.55%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Alpa Laboratories Ltd Stocks COMPARISON

Financials( in Cr) Alpa Laboratories Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Dr Reddys Laboratories Ltd
Price 96.30 1,491.05 1,397.00 3,807.00 5,964.90
% Change 1.58 0.43 3.74 1.02 0.22
Mcap Cr 202.62 357,752.85 112,789.17 101,064.05 99,505.27
Revenue TTM Cr 92.96 43,885.68 15,790.60 7,767.51 24,669.70
Net Profit TTM Cr 12.58 8,560.84 2,513.47 1,823.38 4,507.30
PE TTM 11.13 37.95 27.52 72.36 19.00
1 Year Return 56.46 52.28 54.71 19.24 24.11
ROCE 9.69 16.79 14.76 19.30 25.99
ROE 7.76 16.46 10.66 14.89 21.21
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 134.58 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 19,463.02 -6,228.06
LAST 3M 77,954.71 28,409.22
LAST 6M 138,694.84 74,737.91
LAST 12M 215,251.82 194,497.84

Alpa Laboratories Ltd Information

Stock PE (TTM)
11.13
Promoter Holding
57.29%
Book Value
68.1169
ROCE
9.69%
ROE
7.76%
Description
  • M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In 1998, the Company was converted into a Public Limited Company with effect from September 3, 1998 with the name of "Alpa Laboratories Limited". The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels. In 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. The company has manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark "Alpa" which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. The company has also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, the company has also undertaken contract manufacturing of a large variety of pharmaceuticals. The company has manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. The company has an established product-marketing network covering both metro and mini metro cities, which enable company to reach the existing and potential customers through the network of distributors and dealers spread across the country. For the purpose of marketing the various products, the company`s business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. The Company came out with an Initial Public Offer in July 2007 and got listed on The n The Bombay Stock Exchange and The National Stock Exchange on 06lh August, 2008. The Unit-II oral solid dosage manufacturing facility focusing on containment products such as oral hormonal and other oral hi-potency formulations was made operational at Pithampur Industrial Area in 2012. The Company in FY 2014-15, acquired 100% of the shares of Norfolk Mercantile Private Limited making it a wholly owned subsidiary.

Registered Address

33/2 Pigdamber, A B Road Rau, Indore, Madhya Pradesh, 453446

Tel : 91-731-4294567
Email : mail:alpalabs.in
Website : http://www.alpalabs.in
Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 532878
NSE Code : ALPA
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE385I01010

FAQ’s on Alpa Laboratories Ltd Shares

You can buy Alpa Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Alpa Laboratories Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 24, 2024 01:54 PM the closing price of Alpa Laboratories Ltd was ₹ 96.30.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 24, 2024 01:54 PM, the market cap of Alpa Laboratories Ltd stood at ₹ 202.62.

The latest PE ratio of Alpa Laboratories Ltd as of Apr 24, 2024 01:54 PM is 11.13

The latest PB ratio of Alpa Laboratories Ltd as of Apr 24, 2024 01:54 PM is 0.72

The 52-week high of Alpa Laboratories Ltd share price is ₹ 115.00 while the 52-week low is ₹ 55.00

Download Our

Download App
market app